You can't make a silk purse out of a sow's ear. If the drug doesn't fundamentally work then DEPing it won't help much.
The best SPL can do here is capitalise on the publicity of its capability to to quickly (SPL? quick?) improve a drug by making it easier to administer to patients.
Ann: SPL7013 COVID-19 nasal spray virucidal against SARS-CoV-2, page-131
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $47.38M | |||
| Open | High | Low | Value | Volume |
| 11.5¢ | 11.5¢ | 11.0¢ | $43.20K | 391.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 20946 | 11.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.5¢ | 104392 | 6 |
View Market Depth
| Last trade - 16.10pm 31/05/2024 (20 minute delay) ? |
|
|||||
|
Last
11.3¢ |
Change
0.000 ( 2.17 %) |
||||
| Open | High | Low | Volume | ||
| 11.3¢ | 11.3¢ | 11.0¢ | 82292 | ||
| Last updated 15.58pm 31/05/2024 ? | |||||
| SPL (ASX) Chart |